University of Surrey

Test tubes in the lab Research in the ATI Dance Research

A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC)

McNeish, IA, Ledermann, JA, Webber, LC, James, LE, Kaye, SB, Rustin, GJS, Hall, G, Clamp, A, Earl, HM, Banerjee, SN , Kristeleit, RS, Raja, F, Feeney, A, Lawrence, C, Dawson-Athey, L, Persic, M and Khan, I (2013) A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC) In: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2013-05-31 - 2013-06-04, Chicago, IL.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Authors :
NameEmailORCID
McNeish, IA
Ledermann, JA
Webber, LC
James, LE
Kaye, SB
Rustin, GJS
Hall, G
Clamp, A
Earl, HM
Banerjee, SN
Kristeleit, RS
Raja, F
Feeney, A
Lawrence, C
Dawson-Athey, L
Persic, M
Khan, Ii.khan@surrey.ac.uk
Date : 20 May 2013
Contributors :
ContributionNameEmailORCID
publisherAMER SOC CLINICAL ONCOLOGY,
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology, ONCOLOGY
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:40
Last Modified : 17 May 2017 10:40
URI: http://epubs.surrey.ac.uk/id/eprint/828761

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800